These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3475483)

  • 21. [Synergy between sulbactam and ampicillin or cefoperazone in antimicrobial activity against beta-lactamase producing microorganisms. Results with the use of microdilution broth method].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1990 Jul; 43(7):1214-24. PubMed ID: 2232151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1996). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Shigeta S; Takahashi T; Shiraiwa Y; Ogiwara M; Yoshida H; Imafuku Y; Murai M; Watanabe K; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Igari J; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Kaku M; Ooe H; Mochida C
    Jpn J Antibiot; 1998 Feb; 51(2):69-111. PubMed ID: 9575437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Surveillance of susceptibility of clinical isolates to cefmetazole between 2000 and 2003].
    Sato Y; Abe T; Koga T; Ito K; Tochikawa Y
    Jpn J Antibiot; 2005 Jun; 58(3):303-16. PubMed ID: 16161756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative study on cefmetazole and cefazolin in the treatment of suppurative otitis media].
    Baba S; Ito H; Kinoshita H; Murai K; Wada K; Sambe B; Kawamura S; Sugita R; Fujimaki Y; Kataura A; Sambe S; Watanabe H; Ikeda T; Nameki H; Tanaka M; Osawa H; Ikeda Y; Kawakubo J; Okuda M; Kamio T; Yagi T; Sekine S; Watanabe Y; Nomura Y; Miyakawa K; Yamaguchi H; Totsuka M; Kamio T; Yuge K; Nakamura K; Kubota T; Nakagawa T; Nakagawa M; Komatsuzaki A; Osafune H; Kojima S; Sakamoto Y; Honmura Y; Nakano Y; Imai A; Miyao M; Honda H; Iwasaki E; Iguchi M; Ikeda M; Hondoh J; Noda M; Umeda K; Maruo T; Deguchi K
    Jpn J Antibiot; 1982 Jun; 35(6):1523-52. PubMed ID: 6752467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Basic study on efficacy of cefmetazole against osseous and articular infections (author's transl)].
    Kawashima M; Tamura H; Kitahara Y; Jinyama K
    Jpn J Antibiot; 1982 Mar; 35(3):835-9. PubMed ID: 6954290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nationwide sensitivity surveillance of ciprofloxacin and various parenteral antibiotics against bacteria isolated from patients with severe infections--the first Ciproxan IV special investigation in 2001].
    Yamaguchi K; Ishii Y; Iinuma Y; Yamanaka K; Ichiyama S; Watanabe N; Uehara N; Kaku M; Kurokawa Y; Hayashi M; Hirakata Y
    Jpn J Antibiot; 2003 Dec; 56(6):546-73. PubMed ID: 15007872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
    Deguchi K; Kawamura S; Sugita R; Fujimaki Y; Ohsawa H
    Jpn J Antibiot; 1982 Mar; 35(3):812-20. PubMed ID: 6285017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetic, bacteriological and clinical evaluation of sulbactam/ampicillin in pediatrics].
    Hayashi M; Kida K; Matsuda H; Murase M
    Jpn J Antibiot; 1989 Mar; 42(3):743-53. PubMed ID: 2746854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Determination of the MIC of cefotetan against freshly isolated gram-negative bacilli].
    Deguchi K; Yokota N; Koguchi M; Nakane Y; Fukushima Y; Fukayama S; Nishimura Y; Oda S; Tanaka S; Sato K
    Jpn J Antibiot; 1989 Nov; 42(11):2363-76. PubMed ID: 2621779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study on the drug sensitivity of multiple drug-resistant Staphylococcus aureus].
    Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Satoh K; Toyonaga Y
    Jpn J Antibiot; 1985 Aug; 38(8):2163-70. PubMed ID: 3852898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1982). I. Susceptibility distribution].
    Kosakai N; Igari J; Kumamoto Y; Sakai S; Nishio A; Nagai T; Shigeta S; Shiraiwa Y; Abe K; Tazaki H
    Jpn J Antibiot; 1984 Apr; 37(4):680-722. PubMed ID: 6433064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of in vitro activities of first, second and third generation cephem antibiotics against various pathogens isolated from clinical material in 1985].
    Matsuo K; Tsuzaki Y; Furukawa S; Uete T
    Jpn J Antibiot; 1986 Oct; 39(10):2579-86. PubMed ID: 3100836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Susceptibility of clinically isolated Haemophilus influenzae to cephamycin antibiotics].
    Deguchi K
    Jpn J Antibiot; 1983 May; 36(5):1103-8. PubMed ID: 6604823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. II].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1587-602. PubMed ID: 3900459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental and clinical studies of cefmetazole in the field of oral surgery].
    Minami Y; Taguchi M; Nanba R; Tsuto H; Yamamoto T; Ueda K; Tsushima T; Morihana T; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1982 May; 35(5):1308-21. PubMed ID: 6957626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antimicrobial activity of fosfomycin against beta-lactamase-producing methicillin-sensitive Staphylococcus aureus and methicillin-sensitive coagulase-negative staphylococci].
    Hara T; Araake M; Tsuruoka T; Watabe H
    Jpn J Antibiot; 2003 Apr; 56(2):142-7. PubMed ID: 12825415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution].
    Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C
    Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies of antimicrobial agents against causative organisms isolated from urinary tract infections (1984). III. Secular changes in susceptibility].
    Kosakai N; Kumamoto Y; Sakai S; Hirose T; Shigeta S; Shiraiwa Y; Miura Y; Ogata M; Tazaki H; Iri H
    Jpn J Antibiot; 1986 Nov; 39(11):3019-93. PubMed ID: 3102809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Response to antibiotics of Proteus strains isolated from different types of clinical material].
    Ovetchin PV; Tsyganenko AIa
    Antibiotiki; 1984 Apr; 29(4):272-5. PubMed ID: 6378080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.